Your browser doesn't support javascript.
loading
Impact of last lenalidomide dose, duration, and IMiD-free interval in patients with myeloma treated with pomalidomide/dexamethasone.
Kastritis, Efstathios; Roussou, Maria; Gavriatopoulou, Maria; Kanellias, Nikolaos; Migkou, Magdalini; Eleutherakis-Papaiakovou, Evangelos; Ziogas, Dimitrios C; Fotiou, Despina; Ntanasis-Stathopoulos, Ioannis; Dialoupi, Ioanna; Giannouli, Stavroula; Tsirigotis, Panagiotis; Delimpasi, Sossana; Mparmparousi, Despina; Spyropoulou-Vlachou, Mairylin; Xirokosta, Aikaterini; Terpos, Evangelos; Dimopoulos, Meletios A.
Afiliação
  • Kastritis E; Department of Clinical Therapeutics.
  • Roussou M; Department of Clinical Therapeutics.
  • Gavriatopoulou M; Department of Clinical Therapeutics.
  • Kanellias N; Department of Clinical Therapeutics.
  • Migkou M; Department of Clinical Therapeutics.
  • Eleutherakis-Papaiakovou E; Department of Clinical Therapeutics.
  • Ziogas DC; Department of Clinical Therapeutics.
  • Fotiou D; Department of Clinical Therapeutics.
  • Ntanasis-Stathopoulos I; Department of Clinical Therapeutics.
  • Dialoupi I; Department of Clinical Therapeutics.
  • Giannouli S; Second Department of Internal Medicine, and.
  • Tsirigotis P; Second Department of Internal Medicine, Propaedeutic, ''ATTIKON'' General University Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Delimpasi S; Department of Haematology, Evangelismos Hospital, Athens, Greece; and.
  • Mparmparousi D; Haematology Laboratory and.
  • Spyropoulou-Vlachou M; Immunology Laboratory, Alexandra Hospital, Athens, Greece.
  • Xirokosta A; Haematology Laboratory and.
  • Terpos E; Department of Clinical Therapeutics.
  • Dimopoulos MA; Department of Clinical Therapeutics.
Blood Adv ; 3(23): 4095-4103, 2019 12 10.
Article em En | MEDLINE | ID: mdl-31821457
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores da Angiogênese / Lenalidomida / Mieloma Múltiplo Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Talidomida / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores da Angiogênese / Lenalidomida / Mieloma Múltiplo Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article